A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma
Conditions: Plasmacytoma; Plasmacytoma of Bone; Multiple Myeloma Interventions: Drug: CC-486; Drug: Lenalidomide; Radiation: Radiation Therapy Sponsor: Memorial Sloan Kettering Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2019 Category: Research Source Type: clinical trials